Home » Company Profile » Management Team

Management Team

Jan Lindeman, M.Sc. MBA CEO

Jan has a diverse background in the technology sector. Before joining DDL, he was managing director of a datacenter and cloud service provider, and held commercial leadership roles at Microsoft. Jan has a Master’s degree in applied physics from Delft University of Technology and an MBA from University of Bradford, School of Management.

Leen-Jan van Doorn, Ph. D. CBO

Leen-Jan is responsible for Business Development and one of the founders of DDL. He received his Ph.D. in molecular virology from the Erasmus University of Rotterdam, the Netherlands. He has specialized in molecular typing of infectious organisms such as hepatitis B and C, human papillomavirus and respiratory viruses. Dr. van Doorn has published more than 180 papers in international scientific journals as well as various book chapters.

Ingrid Kolenbrander,CPA CFO

Ingrid is a chartered accountant from the University of Amsterdam. Ingrid worked as senior manager for KPMG and was Finance Director at Schoevers.

Anco Molijn, M.Sc. CTO

Anco has extensive experience in the fields of molecular biology, virology and molecular pathology. Before joining DDL in 1998, he worked at the department of pathology of the Erasmus University of Rotterdam and St. Judes Childrens hospital (Memphis, USA).

Eva van der Veer, M.Sc. VP Diagnostic Services

Eva received her Master’s degree in (Molecular) Biology from Leiden University, the Netherlands. Before joining DDL in 2011, she worked at several diagnostic laboratories where she was responsible for implementation of a diverse range of new molecular assays and technologies. Eva played a leading role in setting up DDL’s fully automated Next Generation Sequencing pipeline specifically designed for viral variant detection.

Maurits de Koning, Ph.D. VP Research & Development Services

Maurits received his Ph.D. in molecular biology from Leiden University, faculty of Medicin, the Netherlands. He has specialized in molecular analysis methods of infectious diseases in the context of clinical trials and diagnostic kits. Dr. de Koning has published more than 70 papers in international scientific journals.

Dr. Wim Quint, Ph. D. President Advisory Board

Wim is one of the founders of DDL and is now president of the Advisory Board. He received his Ph.D. in molecular virology from the University of Nijmegen, the Netherlands. He has specialized in molecular diagnostics of infectious diseases and is a key opinion leader on molecular studies of human papillomavirus. Dr. Quint has published more than 400 papers on various topics in international scientific journals.

Contact us

Just give us a call, send us an e-mail or make an appointment!